Cognitive Performance During Menopause Transition Examined
Measures of cognitive performance show decline from premenopause to later menopause stages among low-income women of color.
Measures of cognitive performance show decline from premenopause to later menopause stages among low-income women of color.
Serotonergic antidepressants are effective for sleep disturbances in perimenopausal and postmenopausal women even without major depressive disorder.
Serum allopregnanolone levels are lower in women with either menstrually related or postmenopausal migraine compared with women without headache.
Severe vitamin D deficiency was linked to lumbar degenerative disease and low back pain in postmenopausal women.
Approximately 20% of women experienced an increase in sleep issues during the presurgery period, although for the majority of women sleep trajectories were generally stable pre- and postsurgery.
Postmenopausal women more often have sleep-onset insomnia disorder and are more likely to screen positive for obstructive sleep apnea.
Epidemiologic data indicate that shorter sleep duration (≤5 hours per night) is associated with lower bone mineral density in postmenopausal women.
The authors acknowledged that the study was limited and plan to follow the group through 4 years of treatment.
The findings suggest a neuroendocrine vulnerability in women with migraine.
The telephone-based treatment would allow for broader patient utilization.